EPH106 Comparison of the Post-Marketing Safety Profile between Influenza and COVID-19 Vaccines: An Analysis of the Vaccine Adverse Event Reporting System (VAERS)
Jul 1, 2022, 00:00 AM
10.1016/j.jval.2022.04.857
https://www.valueinhealthjournal.com/article/S1098-3015(22)01058-0/fulltext
Section Title :
Section Order :
10775
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)01058-0&doi=10.1016/j.jval.2022.04.857